IRCT20200329046892N3招募中2 期
Study of Ivermectin Effectiveness in treatment process, survival and cure rate of COVID-19 patients: a randomized clinical trial
Rasht University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •All Covid-19 patients admitted to the coronavirus ward of Razi Hospital in Rasht for period of April to July 2021
- •Age greater than or equal to 18 years
- •Patients admitted with the following criteria: fever (oral temperature greater than 37.2 ° C), dry cough, severe tiredness or dyspnea
- •At least one of the following criteria : positive PCR OR lung involvement on chest X-ray / CT scan
排除标准
- •Lack of informed consent
- •Lack of patient cooperation
- •Having pulmonary embolism or intravascular thrombosis
- •Any major drug interaction between routine patient's drugs with any of the study drugs
- •Pregnancy and lactation
- •Simultaneous presence in other research study
研究者
相似试验
招募中
3 期
Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 PatientsIRCT20210213050344N1Shiraz University of Medical Sciences375
招募中
不适用
Efficacy of Ivermectin in the treatment of COVID-19IRCT20210901052358N4Shahid Beheshti University of Medical Sciences60
招募中
2 期
Determination the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20200408046987N2Akam Tejarat Fartak Farasoo150
已完成
1 期
Efficacy and safety of Ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic Gabonese adultsMalariaPACTR201908520097051Centre de Recherches Medicales de Lambarene49
尚未招募
2 期
Study to assess efficacy of Ivermectin as prophylaxis of COVID -19CTRI/2020/05/025333R D Gardi Medical College